| Literature DB >> 36180699 |
Céline Legros1, Philippe Dupuis1, Gilles Ferry2, Jean A Boutin3,4.
Abstract
Melatonin, (N-acetyl-5-methoxytryptamine), is a neurohormone which possesses a wide range of biological effects. The effects mediated by melatonin are in part attributed to the antioxidant properties of the molecule. For a long time, melatonin had been described as a ligand of a putative "receptor" present in mammalian brains named MT3. Several studies were thus carried out with the goal of clarifying the nature of this melatonin "receptor." The experimental setup of the binding measurements is unusual. The present chapter aims at describing this technique. This binding site was confirmed independently by several groups, and it was eventually demonstrated that MT3 was the enzyme quinone reductase 2 (NQO2).Entities:
Keywords: 2-iodoMCA-NAT; Binding; Brain; Fast kinetics; Melatonin; NQO2
Mesh:
Substances:
Year: 2022 PMID: 36180699 DOI: 10.1007/978-1-0716-2593-4_30
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745